Navigation Links
JustAnswer(R) and Glaucoma Research Foundation Help Individuals See the Light in Preventing Blindness
Date:6/16/2009

s efforts to inform the public of the specifics of glaucoma," said JustAnswer CEO Andy Kurtzig. "We are proud to help GRF provide around-the-clock assistance to people everywhere looking for answers from Eye Experts in identifying and managing this disease."

Similar to an on-call 24/7 service, JustAnswer provides individuals with quick, immediate, cost-effective online access to verified Medical Experts for answers to vital questions - no health insurance required.

Eye Experts on JustAnswer are available anytime via the Medical category, one of the company's hundred categories.

About the Glaucoma Research Foundation

The Glaucoma Research Foundation is the nation's largest non-governmental funding agency dedicated solely to glaucoma research and education having raised over $45 million to support this mission. In addition to funding projects such as the Catalyst For a Cure Research Consortium and the Shaffer Grants for Innovative Glaucoma Research, GRF is also the "go to" source for education materials such as 'Understanding and Living with Glaucoma' a resource for patients newly diagnosed with the disease. The Foundation's Newsletter, Gleams, reaches over 100,000 glaucoma patients, physicians, scientists and educators throughout the United States. Website: www.glaucoma.org.

About JustAnswer

JustAnswer(R) serves as an online platform where more than 19 million registered users receive answers from 20 thousand doctors, lawyers and other people that JustAnswer collectively calls Experts. Millions with questions come to the site for affordable and timely insight in more than 100 categories, ranging from Medical to Legal. The JustAnswer network enables registered Experts to provide answers within minutes, to help ensure customer s
'/>"/>

SOURCE JustAnswer
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Experts on JustAnswer(R) Projected to Help Thousands During the Thanksgiving Holiday
2. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
3. Glaucoma surgery in the blink of an eye
4. Glaucoma surgery in the blink of an eye
5. Chair of U.S. Preventive Services Task Force Pledges to Recommend Re-evaluation of Recent Glaucoma Findings
6. Looking at Glaucoma as a Systemic Disease
7. Cost of glaucoma medications may impact treatment
8. January is National Glaucoma Awareness Month
9. Upcoming meeting will explore new technologies for glaucoma clinical drug trials
10. Dr. Welsh Self-Test Diagnoses Glaucoma, the Leading Cause of Preventable- Blindness
11. Mayor Bloomberg Declares March 6, 2008 World Glaucoma Day in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... (PRWEB) January 22, 2015 Padre Murphy's and ... supporter of Pro Player Health Alliance (PPHA). The ... Murphy's in getting everyone, including NFL greats, treated for obstructive ... the leading groups supporting the cause in the valley. The ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota ... it means to “Live Fearless.” , The “Faces ... their stories about how they or someone they know has ... living in the moment. By telling these types of stories ...
(Date:1/22/2015)... A new white paper by The Beryl Institute ... long-term care environment as well as provides recommendations for ... “The Power of Person-Centeredness in Long-Term Care: A View ... patient, resident and family experience in long-term care and ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post presenting the ... , Purchasing an accidental death and dismemberment rider for ... of rider provides benefits if the insured dies in an ... form of life insurance. , AD&D is not expensive ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne ... highest annual revenues in the past three years. Today, the ... dresses. , According to the sales manager of the company, ... them in 2015. This point can be reflected on the ...
Breaking Medicine News(10 mins):Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2
... Video Available at dietchallenge.usatoday.com, MCLEAN, Va., March 31 ... its fifth annual USA TODAY Weight-Loss Challenge.,The eight-week series ... ., Each week USA TODAY will follow the ... to their lives, and their waistlines. These,stories range from ...
... combines 2 medications , , SUNDAY, March 30 (HealthDay News) -- ... sense of a trial showing that a drug can lower ... benefit to people at high risk of heart attack and ... statin -- simvastatin -- with ezetimibe, which also lowers LDL ...
... lower restenosis risk and don,t increase mortality probability , , ... small tubing placed in diseased coronary arteries to keep ... heart attack patients, new research shows. , In the ... stents -- the drug in question retards the growth ...
... cancer deaths could be avoided with lifestyle changes, experts ... therapies that could cut cancer deaths in half. , ... recent American Cancer Society report that said as many ... with lifestyle changes, such as quitting smoking, maintaining a ...
... 2008) -- Physician-scientists from NewYork-Presbyterian Hospital/Columbia University Medical ... the American College of Cardiology,s 57th Annual Scientific ... Among the most significant presentations are the following: ... Transplant Allograft Vasculopathy , Dr. Jeffrey ...
... services is associated with enhanced communications between families ... of life for children dying from cancer, according ... and Children,s Hospital Boston. , Published in the ... Oncology, the study,s findings also suggest that the ...
Cached Medicine News:Health News:USA TODAY Weight-Loss Challenge Returns For 5th Year With Eight Weeks of Compelling Stories and Online Features 2Health News:USA TODAY Weight-Loss Challenge Returns For 5th Year With Eight Weeks of Compelling Stories and Online Features 3Health News:Cholesterol Drug Controversy Continues 2Health News:Cholesterol Drug Controversy Continues 3Health News:Drug-Eluting Stents Safe After Heart Attack 2Health News:You May Be the Key to Cancer Prevention 2Health News:You May Be the Key to Cancer Prevention 3Health News:NewYork-Presbyterian/Columbia physician-scientists present at ACC's 57th Annual Scientific Session 2Health News:NewYork-Presbyterian/Columbia physician-scientists present at ACC's 57th Annual Scientific Session 3Health News:Study finds improvement in the care of children with cancer at the end of life 2Health News:Study finds improvement in the care of children with cancer at the end of life 3
(Date:1/23/2015)... LONDON and BOSTON , January ... structure-guided drug discovery and development company, is delighted to announce ... has been awarded to Miles Congreve (Vice President ... co-founder) and Malcolm Weir (Chief Executive Officer and ...
(Date:1/22/2015)... SAN DIEGO, Jan. 22, 2015  ResMed Inc. (NYSE: ... 31, 2014. Revenue for the quarter was $423.0 million, a ... 2013 (a 14 percent increase on a constant currency basis). ... compared to the quarter ended December 31, 2013. Diluted earnings ...
(Date:1/22/2015)... Increasing sophistication among enterprise buyers of language services ... 2015, says Moravia CMO, Renato Beninatto ... market research firm Common Sense Advisory, 15 percent of ... and localization needs. "From a language industry perspective, this ...
Breaking Medicine Technology:Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11Moravia Sees Single-Sourcing as Key Localization Trend in 2015 2
... Lilly and Company (NYSE: LLY ) announced ... Lilly to access innovation being developed outside the company,s ... independent venture capital firms participating in the Mirror Portfolio ... stage of their development. The first is a molecule ...
... 2011 Mylan Inc. (Nasdaq: MYL ) ... launched Voriconazole Tablets, 50 mg and 200 mg, under ... Inc. Mylan was the first company to have filed ... for Voriconazole Tablets and was awarded 180 days of ...
Cached Medicine Technology:Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License First Two Investigational Medicines 2Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License First Two Investigational Medicines 3Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License First Two Investigational Medicines 4